Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 65.47
-2.96 (-4.33%)
Aug 24, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 38.97 billion as of August 24, 2026. Its market cap has decreased by -5.09% in one year.
Market Cap
38.97B
Enterprise Value
35.56B
Revenue
3.95B
Ranking
n/a
PE Ratio
37.79
Stock Price
65.47
ChartMarket Cap Chart
Since June 29, 2020, SHA:603087's market cap has increased from 36.57B to 38.97B, an increase of 6.55%. That is a compound annual growth rate of 1.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 38.97B | -3.82% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iRay Group | 31.62B |
| Intco Medical Technology | 31.36B |
| Andon Health | 29.65B |
| Imeik Technology Development | 27.84B |
| Zhende Medical | 21.58B |
| Jiangsu Hualan New Pharmaceutical Material | 17.49B |
| Winner Medical | 16.90B |
| Shenyang Xingqi Pharmaceutical | 14.20B |